Overview

Lactobacillus Reuteri for Treatment of Uncomplicated UTI in Pregnant Women

Status:
Completed
Trial end date:
2019-06-18
Target enrollment:
Participant gender:
Summary
Prevalence of uro-genital infections during pregnancy move between 7% to 12% in developed countries, meanwhile in developing countries this figure moved between 14% and until 55%, such is the case of Mexico. Meanwhile use of antibiotics for 3 to 7 days had established as a standard of care, the use of non-antibiotic therapy, such as cranberry powder or probiotics for prevention/treatment of this conditions is scarce. Randomized controlled trial aimed to evaluate the safety and efficacy of probiotic vs. antibiotics to treat pregnant women with uncomplicated cystitis or asymptomatic bacteriuria
Phase:
N/A
Details
Lead Sponsor:
Innovacion y Desarrollo de Estrategias en Salud
Collaborator:
BioGaia AB
Treatments:
Amoxicillin-Potassium Clavulanate Combination
Anti-Bacterial Agents
Antibiotics, Antitubercular
Clavulanic Acid
Clavulanic Acids
Nitrofurantoin